Itay Weinstein
Director of Finance/CFO at XTL BIOPHARMACEUTICALS LTD.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Shlomo Shalev | M | 62 | 10 years | |
| Doron Turgeman | M | 56 | 10 years | |
| Iris Shapira Yalon | F | 57 | 4 years | |
| Dobroslav Melamed | M | 46 | 10 years | |
| Osnat Hillel Fain | F | 57 | 9 years | |
| Alexander Rabinovitch | M | 53 | 7 years | |
| Jonathan Schapiro | M | 63 | 10 years | |
| Inbal Tal | F | - |
Yosef Shimony CPA
 Yosef Shimony CPA Miscellaneous Commercial ServicesCommercial Services Yosef Shimony CPA is an accounting firm that offers a range of accounting services, including financial reports, bookkeeping, and salary processing. Yosef Shimony CPA is based in Ramat Gan, Israel, with another office located in Bnei Brak. The company caters to various clients, such as Israeli and international companies, public and private companies, and venture capital funds. The company also provides professional due diligence experience on accounting and taxes. | 1 years |
| Daphna Paran | M | - | 8 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Belkin | M | 81 |
OphthaliX, Inc.
 OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | - |
| Joshua Levine | M | 59 | 6 years | |
| Dafna Cohen | F | 54 | 6 years | |
| Jaron Diament | M | 56 | - | |
| Marc Allouche | M | 50 | - | |
| Roger Kornberg | M | 77 |
OphthaliX, Inc.
OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | - |
| Pnina Fishman | M | 74 |
OphthaliX, Inc.
OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | - |
| David Grossman | M | 49 | 5 years | |
| Amit Yonay | M | 54 | - | |
| Oded Nagar | M | 55 | 4 years | |
| David Bassa | M | 62 | 4 years | |
| BILL Kessler | M | 57 | 4 years | |
| Moshe Mittelman | M | 71 | - | |
| Gil Ben-Menachem | M | 56 |
OphthaliX, Inc.
OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | - |
| Lewis F. Neville | M | - | 7 years | |
| Daniel Spira | M | 69 | - | |
| Barak Singer | M | 52 |
OphthaliX, Inc.
OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | 1 years |
| Ronen Twito | M | 49 | 4 years | |
| Kenneth Zuerblis | M | 64 | 1 years | |
| Guy Regev | M | 55 |
OphthaliX, Inc.
OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | - |
| Boaz Shweiger | M | - | 1 years | |
| Michael Weiss | M | 58 | - | |
| Samuel H. Rudman | M | - | - | |
| Laurence Charney | M | 76 | - | |
| Ben-Zion Weiner | M | 80 | 1 years | |
| David Kestenbaum | M | 59 | 3 years | |
| Reza Fathi | M | 69 | 4 years | |
| Jonathan Burgin | M | 63 | 7 years | |
| Jennifer Good | F | 59 | - | |
| Ronald Bentsur | M | 58 | 3 years | |
| Neil Graham | M | 65 | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Israel | 40 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Itay Weinstein
- Personal Network
